Approval · Notice of Compliance 37036 · 2026
BLEOMYCIN FOR INJECTION: Notice of Compliance 37036
Issued March 3, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37036
- Date
- March 3, 2026
- Company
- Marcan Pharmaceuticals Inc.Ottawa, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- BLEOMYCIN FOR INJECTION (Fresenius Kabi Canada Ltd)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BLEOMYCIN FOR INJECTION | 02566346 | Approved |
Medicinal ingredients
- BLEOMYCIN SULFATE 15 UNIT per VIAL